These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11694825)

  • 1. Activity of HIV-1 integrases recovered from subjects with varied rates of disease progression.
    Katzman M; Harper AL; Sudol M; Skinner LM; Eyster ME
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):203-10. PubMed ID: 11694825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.
    Harper AL; Skinner LM; Sudol M; Katzman M
    J Virol; 2001 Aug; 75(16):7756-62. PubMed ID: 11462051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophile selection for the endonuclease activities of human, ovine, and avian retroviral integrases.
    Skinner LM; Sudol M; Harper AL; Katzman M
    J Biol Chem; 2001 Jan; 276(1):114-24. PubMed ID: 11024025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors.
    Skinner LM; Lamers SL; Sanders JC; Eyster ME; Goodenow MM; Katzman M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):99-110. PubMed ID: 9768617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping target site selection for the non-specific nuclease activities of retroviral integrase.
    Katzman M; Sudol M; Pufnock JS; Zeto S; Skinner LM
    Virus Res; 2000 Jan; 66(1):87-100. PubMed ID: 10653920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/visna virus chimeric proteins.
    Katzman M; Sudol M
    J Virol; 1998 Mar; 72(3):1744-53. PubMed ID: 9499023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of enzymatic activities of the HIV-1 and HFV integrases to their U5 LTR substrates.
    Oh YT; Shin CG
    Biochem Mol Biol Int; 1999 Apr; 47(4):621-9. PubMed ID: 10319414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural selection results in conservation of HIV-1 integrase activity despite sequence variability.
    Reinke R; Steffen NR; Robinson WE
    AIDS; 2001 May; 15(7):823-30. PubMed ID: 11399954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of chimeric enzymes between caprine arthritis--encephalitis virus, maedi--visna virus and human immunodeficiency virus type 1 integrases expressed in Escherichia coli.
    Berger N; Heller AE; Störmann KD; Pfaff E
    J Gen Virol; 2001 Jan; 82(Pt 1):139-148. PubMed ID: 11125167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient gap repair catalyzed in vitro by an intrinsic DNA polymerase activity of human immunodeficiency virus type 1 integrase.
    Acel A; Udashkin BE; Wainberg MA; Faust EA
    J Virol; 1998 Mar; 72(3):2062-71. PubMed ID: 9499061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 integrase: a target for new AIDS chemotherapeutics.
    Anthony NJ
    Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: design and characterization of the enzymatic properties.
    Shadrina O; Krotova O; Agapkina J; Knyazhanskaya E; Korolev S; Starodubova E; Viklund A; Lukashov V; Magnani M; Medstrand P; Karpov V; Gottikh M; Isaguliants M
    Biochimie; 2014 Jul; 102():92-101. PubMed ID: 24594066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.
    Sinha S; Grandgenett DP
    J Virol; 2005 Jul; 79(13):8208-16. PubMed ID: 15956566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking.
    Jenkins TM; Esposito D; Engelman A; Craigie R
    EMBO J; 1997 Nov; 16(22):6849-59. PubMed ID: 9362498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.
    Katzman M; Sudol M
    J Virol; 1995 Sep; 69(9):5687-96. PubMed ID: 7637015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide-based assays for integrase activity.
    Merkel G; Andrake MD; Ramcharan J; Skalka AM
    Methods; 2009 Apr; 47(4):243-8. PubMed ID: 19010419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
    Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase.
    Konsavage WM; Sudol M; Katzman M
    Virology; 2008 Sep; 379(2):223-33. PubMed ID: 18687451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.